Recombinant Rat ADORA3 Protein，His

ADORA3 (Adenosine A3 receptor) is a member of the adenosine receptor family, which plays a pivotal role in various physiological processes and pathophysiological conditions. As a G protein-coupled receptor, ADORA3 is involved in modulating immune responses, inflammation, and cardioprotection, making it a potential therapeutic target for diseases such as cancer, cardiovascular disorders, and neurodegenerative diseases. The receptor's unique signaling pathways, mediated through its interaction with adenosine, have garnered significant interest in pharmacology and drug development. Recent research has focused on the characterization of recombinant ADORA3 proteins to elucidate their functional properties and to facilitate the screening of novel ligands and drugs. By producing ADORA3 in various expression systems, researchers aim to study its structure-function relationships and interactions with signaling partners. The development of ADORA3 recombinant proteins enhances our understanding of how this receptor can be modulated in a therapeutic context, paving the way for innovative treatments targeting adenosine signaling pathways. This research is critical for uncovering the role of ADORA3 in disease mechanisms and for developing effective pharmacological agents that can specifically target this receptor to improve patient outcomes.